StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) stock

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30240% above fair value
$144.46−3.30 (-2.23%)

Close on Nov 16, 2026Market cap $356.41BP/E 115.6Yield 2.27%

Merck price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Merck's price to sales ratio was 5.5× on Nov 10, 2026, against 4.1× a year earlier. Over the last 5 years it ranged from 3.1× to 5.6×, with a median of 4.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 20265.5×+1.4
2025Dec 31, 20254.1×+0.1
2024Dec 31, 20244.0×−0.7
2023Dec 29, 20234.7×−0.1
2022Dec 30, 20224.8×+0.6
2021Dec 31, 20214.2×−1.5
2020Dec 31, 20205.7×+0.6
2019Dec 31, 20195.1×+0.2
2018Dec 31, 20185.0×+1.1
2017Dec 29, 20173.9×−0.2
2016Dec 30, 20164.1×+0.3
2015Dec 31, 20153.8×−0.1
2014Dec 31, 20143.9×+1.1
2013Dec 31, 20132.7×+0.1
2012Dec 31, 20122.6×+0.3
2011Jan 31, 20112.3×−0.2
2010Dec 31, 20102.5×–

More Merck figures

See a number that looks wrong?